可解释的深度学习框架,以了解阿尔茨海默病患者大脑中的分子变化:对微质激活和性别差异的影响
Maitry Ronakbhai Trivedi1,2, Amogh Manoj Joshi1,2, Jay Shah1,2
1School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
npj aging
|July 16, 2025
概括
人工智能 (AI) 模型揭示了阿尔茨海默病 (AD) 大脑区域中共享和独特的基因表达模式. 这项研究确定了一种新的与性别相关的基因对 (ZFX/ZFY),与阿尔茨海默氏症女性的神经元损失较大有关.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 基因表达失调是复杂的,并且在不同大脑区域之间有所不同.
- 了解转录组签名对于识别AD生物标志物和治疗点至关重要.
- 目前的分析方法,如差异基因表达 (DGE),可能无法完全捕捉分子变化.
研究的目的:
- 开发和应用一个深度学习框架来分析AD脑组织中的基因表达.
- 识别AD中不同大脑区域的共同和特定的转录组签名.
- 发现新的分子机制,包括性别特异性差异,是AD病原体的基础.
主要方法:
- 开发了使用AD和控制脑组织 (DLPFC,PCC,HCN) 批量RNA测序数据的多层感知子 (MLP) 深度学习模型.
- 应用无监督的维度转换来推断疾病进展轨迹.
- 利用SHapley添加式扩展 (SHAP) 进行模型解释性,并确定了关键AD涉及的基因用于网络分析.
主要成果:
- 在独立数据集 (MAYO,MSBB) 上,MLP模型展示了强大的分类和预测性能.
- 确定了与AD相关的微质和性别特异的神经元模块中共享的转录基因特征.
- 发现了一种新的与性别相关的转录因子对 (ZFX/ZFY),与女性阿兹海默症患者的神经元损失增加有关.
结论:
- 深度学习为AD分子病理学提供了强大的洞察力,超越了传统的DGE分析.
- 这项研究阐明了微妙的分子变化,并确定了与AD有关的关键细胞通路.
- 确定了与性别相关的基因对,为AD神经退行症中性别二态的新机制性解释提供了新的解释.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35


